Antidiabetic Potentials of Aqueous Leaf Extracts of Momordica balsamina Linn and Leptadenia hastata (Pers) Decne Alone and in Combination in Streptozotocin-Induced Diabetic Rats

Nafisatu Kabir1*, Ismail A. Umar2, Dorcas B. James2, Hajiya M. Inuwa2, Muhammad K. Atiku3
1Department of Biochemistry, Federal University Dutse, Jigawa State-Nigeria.
2Department of Biochemistry, Ahmadu Bello University Zaria, Kaduna State-Nigeria.
3Department of Biochemistry, Bayero University Kano State-Nigeria.

Corresponding Author: ; Tel: +2348142100902
Recieved Date: December 19, 2018; Accepted Date: January 27, 2019; Published Date: 04 February 2019
Citation: Kabir N, Umar IA, James DB, Inuwa HM, Atiku MK. Antidiabetic Potentials of Aqueous Leaf Extracts of Momordica balsamina Linn and Leptadenia hastata (Pers) Decne Alone and in Combination in Streptozotocin-Induced Diabetic Rats. Trop J Nat Prod Res. 2019; 3(1):10-16.
Copyright: © 2019 Kabir et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Metabolic derangements associated with Diabetes Mellitus (DM) require multiple therapeutic approaches to improve glycaemia outcomes and thus prevent onset of long-term complications. Composite antidiabetic plants mixture appears to be more therapeutically effective than the individual components through their synergistic or additive effect. The present study evaluated the antidiabetic potentials of the aqueous leaf extracts of Momordica balsamina (MB) and Leptadenia hastata (LH) alone and in combination in streptozotocin (STZ)-induced diabetic rats. Acute oral toxicity study was conducted at 2000 mg/kg body weight as per the OECD guidelines to determine the safe dose range of each plant extract alone and in combination. Graded doses of LH, MB and their combination (100-400 mg/kg) were screened acutely for antidiabetic activity at specific time intervals in rats made diabetic with a single intraperitoneal injection of STZ (60 mg/kg) to determine their effective doses (ED). Antidiabetic activities of the ED were sub-acutely (28 days) evaluated by measuring biochemical parameters in blood, serum and liver homogenate of STZ-induced rats. The ED at 400 mg/kg (LH), 200 mg/kg (MB) and 400+200 mg/kg (LH+MB) mg/kg proved to significantly decrease levels of blood glucose, glycated heamoglobin (HbA1c), glucose-6-phosphatase (G6P) and increase levels of serum insulin, total heamoglobin (Hb) and hexokinase (HK) in STZ-induced diabetic rats when compared to normal rats. These results demonstrated the antidiabetic activity of the aqueous leaf extracts of L. hastata and M. balsamina and their combination, thus validating their ethno-medicinal usage in the management of DM and its complications.

Keywords: Momordica balsamina, Leptadenia hastata, aqueous extract, antidiabetic, streptozotocin.
Back to Articles

ISSN: 2616-0684 (Print)
ISSN: 2616-0692 (Online)
DOI: 10.26538/tjnpr
Index Copernicus Value (ICV) for 2017: 59.83
Scopus citescore 0.3 (2020)

Indexing & Abstracting

citescore 0.3 (2020)

j-gate logo

International Innovative Journal Impact Factor

African Index Medicus


Index Copernicus International

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

Crossref Content Registration logo

WorldCat Discovery Service

Geneva Foundation for Medical Education and Research